I mentioned a little while ago that we had been in contact with the FDA about getting some advice on our clinical trial design. That's progressed a bit with some emails back and forth.
We also managed to get in contact with Senator Ron Wyden (OR) who sits on the funding committee of the FDA as well as the committee on aging. Dr. Summerton had dinner with him last Friday and he agreed to help us get in contact with the people we need to talk to at the FDA.
Lo and behold last night Dr. Summerton received a phone call from the FDA asking about our project.
Getting advice from the FDA in our experimental design is absolutely vital in keeping the costs down while simultaneously running an experiment that complies with the quality requirements of the Food and Drug Administration.
In the meantime Dr. Moss is trying to get in contact with Governor Rick Perry (TX) To help with a funding proposal to the states while Dr. Summerton has been in contact with Governor John Kitzhaber (OR) to also provide advice on how to level a proposal to the 50 states.
A project to get a remarkable new drug for revival of memory in Alzheimer's patients.
Friday, April 26, 2013
Tuesday, April 23, 2013
Our First Spot on Television
The KVIA station in El Paso Texas picked up our story yesterday. Whitney Burbank called up Brain-Tools at about two pm looking for Dr. Moss' phone number, and the story ran on the 10:00 news. It was a remarkably fast turnaround and a very well done story.
You can watch the story at their website here.
You can watch the story at their website here.
Friday, April 12, 2013
New Crowdfunding Site: We can take Credit Cards Now!
We have started up a Brain-Tools crowd funding page over at Rockethub to collect contributions to the MSF development project. This site is set up to help fund new start up projects by public contribution, just as we had intended to do with our treatment for Alzheimer's. Our first fundraising goal is $100,000 collected over 90 days which will go to developing our memory tests and pay for equipment we'll be using to safely manufacture MSF for our long term safety study (the second stage described in our funding plan).
Please take a moment to help us with the first leg of our crowd funding push to make MSF available to Alzheimer's patients. Share this site with anyone that would have interest in a more effective treatment for the debilitating effects of memory loss caused by this disease.
Brain-Tools Crowdfunding Project
Please take a moment to help us with the first leg of our crowd funding push to make MSF available to Alzheimer's patients. Share this site with anyone that would have interest in a more effective treatment for the debilitating effects of memory loss caused by this disease.
Brain-Tools Crowdfunding Project
Thursday, April 11, 2013
Podcast on Alzheimer's Speaks Radio
Dr. Moss gave an interview on Alzheimer's speaks radio today which you can listen to below on his experiences with developing MSF and how we plan to proceed from there. You can also listen to the interview on the Alzheimer's speaks site here. The interview with Dr. Moss begins at 61:34.
Monday, April 8, 2013
Assays for Memory Improvement After Treatment with MSF in Alzheimer's Patients
I had the
opportunity to see the memory assays we'll be giving to Alzheimer's patients to
assess their improvement, and I loved them. They were easy to understand, could
be given quickly without too much strain on the subject, and the peer reviewed
research indicated they were exceptionally good at discerning memory abilities
in both Alzheimer's patients and normals. The tests were researched by Dr. Awh
and Dr. Vogel, and they are currently working on formatting the tests so that
they can be given remotely by trained testers over Skype or a similar sort of
software. This is pretty important if you're going to be testing 400 people a
week over a potentially very large area. Of course in addition to these quick
assessments our Contract Research Organizations (CROs) will also be using the
same methods that Aricept used to test donepezil on a roughly monthly basis so
that our they can determine relative effectiveness of the drugs.
In the
meantime Dr. Summerton, co-manager of Brain-Tools, has written our first letter
to the FDA about helping us set up Adaptive trials, and we just got our first
responses! Details will be forthcoming.
Friday, April 5, 2013
Getting the Word Out
Website Completed
Although
we've been tweaking it a bit here and there, the website has been pretty much
completed, with all of the information on our project to get MSF to Alzheimer's
patients available now. One of the key features up there right now is an
animation Jon Perry of Stated Clearly created for us to explain the mechanism
of MSF's restoral of memory in sufferers of Alzheimer's. The animation explains
why MSF performs so remarkably compared to what's available on the market, and
does so for a general audience.
With the
completion of the website we've started focusing on how to best disseminate our
project to the public. Because we rely on contributions from the public as
opposed to traditional venture capitalists we have a lot more stake in having
our project heard about by private individuals. Whereas a mainline
Biopharmaceutical company might put out a few press releases to drum up
enthusiasm in their existing investors, we need everyone with a stake in
Alzheimer's treatments to hear about us. Currently Dr. Moss is working with a
PR consultant and some volunteer assistance from his daughters to write letters
to talk shows, podcasts and blogs asking if they'll share our story. We should
start sending the letters out within the next few days, so check back here to
see if we end up on anything you listen to. If you have any suggestions for slightly obscure
podcasts or talk shows we should write to, please send them to me at
patrick.summerton@brain-tools.com.
And now for the video I was touting in the first
paragraph!
Subscribe to:
Posts (Atom)